Truvada Sales Data
| Rank 22 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Truvada U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 22 | $542,846 | 0.03% | 532 | -0.56% |
| Q3 2013 | 22 ( 2) |
$542,684 | -1.67% | 535 | -4.12% |
| Q2 2013 | 20 ( 1) |
$551,873 | 2.78% | 558 | 1.82% |
| Q1 2013 | 21 (2) |
$536,928 | -5.11% | 548 | -8.51% |
| Q4 2012 | 19 (1) |
$565,853 | 2.64% | 599 | 3.81% |
| Q3 2012 | 18 (5) |
$551,280 | 1.56% | 577 | 0.52% |
| Q2 2012 | 23 | $542,835 | -0.60% | 574 | -0.52% |
| Q1 2012 | 23 (2) |
$546,098 | 8.31% | 577 | 2.85% |
| Q4 2011 | 25 | $504,186 | 3.43% | 561 | 3.31% |
| Q3 2011 | 25 (2) |
$487,444 | 1.15% | 543 | 1.69% |
| Q2 2011 | 27 (1) |
$481,921 | 8.66% | 534 | 1.71% |
| Q1 2011 | 28 | $443,501 | n/a | 525 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
Related news
| Date | Article |
|---|---|
| December 13, 2022 | USPSTF Recommends PrEP for Reducing Risk for HIV Acquisition |
| December 1, 2022 | On World AIDS Day, White House Announces Plan to End Epidemic by 2030 |
| September 8, 2022 | Texas Judge Says ACA Cannot Require Coverage for PrEP |
| September 8, 2022 | Texas Judge Says Obamacare Can't Require Coverage for Meds That Prevent HIV |
| June 29, 2022 | PrEP Stigma High Among U.S. Male Couples |
